December 2025 Quarterly Activity Report & Appendix 4C
Filed with ASX · · 9 pages · English
Firebrick Pharma Limited on 6ix
Story so far
Earlier from Firebrick Pharma
- Nasodine Throat Spray Product Launch in Singapore
- Firebrick announces new product Nasodine Throat Spray
- September 2025 Quarterly Activity Report & Appendix 4C
- Firebrick Secures Investment from Philippines Partner
- Firebrick receives $250,000 R&D Tax Incentive
Later from Firebrick Pharma
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- Registration Agreement and Approval of Nasodine in Indonesia
- Trading Halt
- Firebrick Secures $1.5 million via Placement
- March 2026 Quarterly Activity Report & Appendix 4C
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma